Endometrial adenocarcinoma in young-aged women: a Turkish population study

Eur J Gynaecol Oncol. 2015;36(6):667-71.

Abstract

Purpose of investigation: The present study aims to investigate the incidence, clinicopathological features, and experience of treat- ment outcomes of patients with endometrial adenocarcinoma (EC) at ≤ 40 years of age in a gynecologic oncology reference center in Ankara, Turkey.

Materials and methods: This retrospective study included 577 patients with EC, diagnosed and treated between 2007 and 2013.

Results: The incidence of EC ≤ 40 years of age was 5.1% (n: 30). The mean age at diagnosis was 35.5 (range: 27-40). Most of the patients with EC were overweight or obese. However, 23% had normal body mass index (BMI). Infertility was seen as a risk factor in 38.4%. The mean duration of postoperative follow-up was 38.3 months with rates of disease persistence and recurrence 14.2% and 28.5%, respectively.

Conclusion: The disease is diagnosed usually in its early stage and has a good prognosis. Appropriately selected patients with fertility desire have the opportunity to conceive with conservative management.

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / therapy
  • Adult
  • Body Mass Index
  • Endometrial Neoplasms / epidemiology
  • Endometrial Neoplasms / pathology*
  • Endometrial Neoplasms / therapy
  • Female
  • Fertility
  • Humans
  • Neoplasm Staging
  • Retrospective Studies